Arecor Therapeutics Alternatives & Competitors

12 companies similar to Arecor Therapeutics — Advancing today’s therapies to enable healthier lives

Verdiva Bio

Transforming lives by accelerating innovation in cardiometabolic health

76 Series A $411.00M

London, United Kingdom

Biotechnology Pharmaceutical

Nucleome Therapeutics

Nucleome Therapeutics is a biotechnology company using 3D genomics to discover precision m...

52 Series A $45.20M

Oxford, United Kingdom

Scribe Therapeutics

CRISPR by Design™

87 Series B $140.00M

Alameda, United States

Biotechnology

Tentarix Biotherapeutics

Enabling Intelligent Therapies with Multifunctional Biologics

56 Series B $93.00M

San Diego, United States

Biotechnology Life Sciences

Track all Arecor Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Recursion

Decoding Biology to Radically Improve Lives

767 IPO $1.30B

Salt Lake City, United St...

AI Biotechnology +3

BigHat Biosciences

BigHat Biosciences is a novel protein therapeutics company and developer of an AI-guided a...

96 Series B $99.30M

San Mateo, United States

Biotechnology Pharmaceutical

Endeavor BioMedicines

Boldly pursuing development of transformational medicines that may restore hope for patien...

52 Series C $295.50M

San Diego, United States

Biotechnology Health Care

Engitix Therapeutics

Decoding the ECM space to unlock unprecedented therapies for chronic diseases

63 Series A $59.00M

London, United Kingdom

Biotechnology Health Care +1

NodThera

Treating chronic disease by targeting inflammation at its source

22 Series B $77.08M

Philadelphia, United Stat...

Biotechnology Health Care +1

Bonum Therapeutics

Systemic delivery, local activity

25 Series A $93.00M

Seattle, United States

Biotechnology Pharmaceutical

AbolerIS Pharma

Immune Tolerance, Restored.

13 Series A $29.88M

Belgium

Gosta Labs

Focus on care

13 Seed $8.70M

Espoo, Finland

About Arecor Therapeutics

Advancing today’s therapies to enable healthier lives

Services

Drug development for diabetes, Oral delivery of peptides, Development of enhanced therapeutic medicines using Arestat technology

Target Customers

Pharmaceutical companies, Medtech companies, Healthcare providers focusing on diabetes and cardiometabolic diseases

Taxonomy

Biopharmaceutical, Innovative Formulation, Arestat Platform, Diabetes Treatment, Proprietary Products, Therapeutic Enhancement, Ready-to-Administer Formats, Ready-to-Use Formats, Stability Improvement, Liquid Product Technology, Lyo-to-Liquid Conversion, Intravenous To Subcutaneous, High Concentration MAbs, Differentiated Biosimilars, Vaccine Stability

Business Model

B2B, B2B2C, D2C

Revenue Model

Licensing, Product Sales, Service Fee

Frequently Asked Questions

Top alternatives to Arecor Therapeutics include Verdiva Bio, Nucleome Therapeutics, Scribe Therapeutics, Tentarix Biotherapeutics, Recursion. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to Arecor Therapeutics based on industry overlap, target customers, and business model.

Advancing today’s therapies to enable healthier lives

Don't just read about them. Follow them.

BounceWatch watches Arecor Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Arecor Therapeutics Profile Verdiva Bio Alternatives Nucleome Therapeutics Alternatives Scribe Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Arecor Therapeutics on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 14 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.